Dollex Agrotech Limited has received board approval to incorporate a wholly-owned subsidiary, Dollex Green Ventures Pvt. Ltd. The new entity will focus on renewable energy, including biogas, compressed biogas (CBG), and bio-fertilizers. While the initial capital commitment is a modest Rs 1 lakh, this move marks the company's strategic pivot into the green energy sector, signaling future growth potential in sustainable energy markets.
Dollex Agrotech Diversifies into Green Energy
Initial Capital: Rs 1 lakh | Stake: 100%
Reader Takeaway: Strategic entry into high-growth renewable energy sector via new subsidiary; scale remains small at inception.
What just happened
Dollex Agrotech Limited has officially approved the incorporation of a new wholly-owned subsidiary, Dollex Green Ventures Pvt. Ltd. The company intends to use this entity as a corporate vehicle to penetrate the renewable energy market. The Board of Directors finalized this decision during their meeting on October 19, 2026. The parent company will hold 99.999% of the shares, with the remaining 0.001% held by a nominee for regulatory compliance.
Why this matters
This expansion signals a transition for Dollex Agrotech from its existing business scope into the sustainability domain. The focus areas for the subsidiary include biogas, Compressed Biogas (CBG), bioenergy, biomethane, and organic fertilizers. This diversification could eventually provide the company with new revenue streams linked to India's growing green energy infrastructure requirements.
The investment structure
The subsidiary is being launched with a modest initial paid-up capital of Rs 1 lakh, split into 10,000 equity shares with a face value of Rs 10 each. The cash-based subscription confirms that Dollex Agrotech maintains full beneficial ownership of the new venture.
What to track next
Investors should look for further filings regarding the actual commencement of operations by the new subsidiary. Key metrics to monitor will include potential project announcements, the scale of future capital infusion, and government partnerships in the biofuel and CBG space that could validate this diversification strategy.